View in EDS

Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors.

Saved in:
Bibliographic Details
Title: Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors.
Authors: Marzi L; Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., Agama K; Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., Murai J; Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., Difilippantonio S; Laboratory of Animal Sciences Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., James A; Laboratory of Animal Sciences Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Peer CJ; Clinical Pharmacology Program, Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., Figg WD; Clinical Pharmacology Program, Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., Beck D; Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, and The Purdue Center for Cancer Research, Purdue University, Lafayette, Indiana., Elsayed MSA; Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, and The Purdue Center for Cancer Research, Purdue University, Lafayette, Indiana., Cushman M; Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, and The Purdue Center for Cancer Research, Purdue University, Lafayette, Indiana., Pommier Y; Developmental Therapeutics Branch & Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. pommier@nih.gov.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2018 Aug; Vol. 17 (8), pp. 1694-1704. Date of Electronic Publication: 2018 May 10.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-8514
DOI:10.1158/1535-7163.MCT-18-0028